CoChat

Economic Burden of Fungal Diseases in the United States

Open access
Benedict, Kaitlin, Whitham, Hilary K, Jackson, Brendan R · 2022 · Open Forum Infectious Diseases

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

We conservatively estimated the US economic burden of fungal diseases as $11.5 billion in 2019: direct medical costs ($7.5 billion), productivity loss due to absenteeism ($870 million), and premature deaths ($3.2 billion). An alternative “value of statistical life” approach yielded >$48 billion. These are likely underestimates given underdiagnosis and underreporting.

Overview

Integrity signals

Registry

Crossref · 10.1093/ofid/ofac097

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. Bureau of Labor Statistics., May 2019 National Occupational Employment and Wage Estimates United States
  2. Office of the Assistant Secretary for Planning and Evaluation., 2016, Guidelines for Regulatory Impact Analysis

Cited by

See all 108

Metadata

Authors
Benedict, K., Whitham, H. K., & Jackson, B. R.
Affiliations
Centers for Disease Control and Prevention (US)
Corresponding author
Benedict, Kaitlin
Venue
Open Forum Infectious Diseases
Published
2022-03-23
Volume
9
Issue
4
Pages
ofac097-ofac097
ISSN
2328-8957 (ISSN-L)
OpenAlex
W4220891471
Cited by
108
References
16
Citations by year
2026: 12 · 2025: 35 · 2024: 31 · 2023: 24 · 2022: 6
FWCI
17.33
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Open Forum Infectious Diseases (publishedVersion, public-domain)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Centers for Disease Control and Prevention
Topics
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
fungal diseases, economic burden, direct medical costs, productivity loss, absenteeism, premature mortality, value of a statistical life, underdiagnosis, underreporting, cost estimation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.